Skip Navigation
  • You are viewing a Navigating Care library resource.
  • Go to Library

Treatment of Acute Myeloid Leukemia in Remission

Treatment of acute myeloid leukemia (AML) during the remission phase depends on the subtype of AML and may include:

  • combination chemotherapy that includes
  • maintenance therapy with , for people whose AML has a mutation in the FLT3 gene
  • maintenance therapy with chemotherapy
  • high-dose chemotherapy and stem cell transplant using the patient's stem cells
  • high-dose chemotherapy, with or without radiation therapy, or reduced-intensity therapy, followed by a stem cell transplant using donor stem cells

To learn more about these treatments, see the Treatment Option Overview.

Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.

This information is not intended to replace the advice of a doctor. Navigating Care disclaims any liability for the decisions you make based on this information. This information was sourced and adapted from Adapted from the National Cancer Institute's Physician Data Query (PDQ®) Cancer Information Summaries on www.cancer.gov.
This information updated April 1, 2024.

Learn more:

© 2024 Navigating Care, Inc. Patient Engagement Portal v.6.0 | (800) 925-4456 | Privacy Policy | Terms of Use | Certification
This site does not provide medical advice, diagnosis, or treatment.